What Pmv Pharmaceuticals, Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Mack David Henry | President and CEO | Oct 27 | Exercise / conversion · M | +220,643 | $1.37 | +$302K | 451,109 |
| Orbimed Advisors Llc | 10% owner | Oct 23 | Open-market sale · S | −1,000,000 | $1.52 | −$1.52M | 4,975,291 |
| Orbimed Advisors Llc | 10% owner | Sep 10 | Open-market sale · S | −500,000 | $1.80 | −$900K | 5,975,291 |
| Jalota Deepika | Chief Development Officer | Jul 01 | Sale for tax withholding · S | −33,065 | $1.06 | −$35.2K | 89,959 |
| Ticktin Robert | General Counsel & COO | Jul 01 | Sale for tax withholding · S | −23,151 | $1.06 | −$24.7K | 98,695 |
| Mack David Henry | President and CEO | Jul 01 | Sale for tax withholding · S | −58,411 | $1.06 | −$62.2K | 536,133 |
| Carulli Michael | Chief Financial Officer | Jul 01 | Sale for tax withholding · S | −28,249 | $1.06 | −$30.1K | 60,146 |
| Mack David Henry | President and CEO | Jan 03 | Exercise / conversion · M | +17,709 | $0.53 | +$9.39K | 551,919 |
| Mack David Henry | President and CEO | Dec 03 | Exercise / conversion · M | +91,750 | $0.53 | +$48.6K | 534,210 |
| Jalota Deepika | Chief Development Officer | Sep 11 | Open-market sale · S | −7,218 | $1.50 | −$10.9K | 118,283 |
| Carulli Michael | Chief Financial Officer | Sep 11 | Open-market sale · S | −2,891 | $1.50 | −$4.35K | 88,395 |
| Jalota Deepika | Chief Development Officer | Jan 18 | Grant / award · A | +95,555 | — | — | 125,501 |
| Mack David Henry | President and CEO | Jan 18 | Grant / award · A | +163,890 | — | — | 442,460 |
| Carulli Michael | Chief Financial Officer | Jan 18 | Grant / award · A | +82,220 | — | — | 91,286 |
| Orbimed Advisors Llc | 10% owner | Nov 22 | Open-market sale · S | −87,786 | $2.23 | −$196K | 0 |
| Mack David Henry | President and CEO | Nov 10 | Gift · G | +85,307 | — | — | 165,307 |
| Mack David Henry | President and CEO | Nov 10 | Gift · G | −85,307 | — | — | 278,570 |
| Mack David Henry | President and CEO | Oct 18 | Exercise / conversion · M | +198,407 | $0.53 | +$105K | 363,877 |
| Alland Leila | Chief Medical Officer | Sep 15 | Open-market sale · S | −6,291 | $6.62 | −$41.6K | 45,909 |
| Jalota Deepika | Chief Development Officer | Sep 15 | Open-market sale · S | −4,104 | $6.62 | −$27.2K | 29,946 |
Loading...
